CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients

Table 2

Comparison of fractalkine V2491 and T280M genotypes between patients and control.

	ESRD (n = 100)	Healthy control (n = 100)	OR (95%)
V2491
GG n (%)	69 [69%]	83 [83%]	1.5 [1.03–2.3]	= 0.03
GA n (%)	30 [30%]	15 [15%]
AA n (%)	1 [1%]	2 [2%]
G n (%)	168 [84%]	181 [90.5%]		= 0.05
A n (%)	32 [16%]	19 [9.5%]
T280M
TT n (%)	70 [70%]	86 [86%]	1.7 [1.1–2.7]	= 0.01
TA n (%)	29 [29%]	13 [13%]
AA n (%)	1 [1%]	1 [1%]
T n (%)	169 [84.5%]	185 [92.5%]		= 0.01
A n (%)	31 [15.5%]	15 [7.5%]

For genotypes. For alleles.